Skip to main content
. Author manuscript; available in PMC: 2022 Feb 10.
Published in final edited form as: J Control Release. 2020 Dec 13;330:173–184. doi: 10.1016/j.jconrel.2020.12.007

Fig. 6. In vitro assay for cancer cell inhibition and synergistic effect of 6WJ/HTL/miR122 and 6WJ/HTL/PTX nanoparticles.

Fig. 6.

A. MTT assay (n=3; mean ± SD). B. Caspase-3 assay. C. Synergetic cytotoxic effect between 6WJ/HTL/miR122 and 6WJ/HTL/PTX nanoparticles were assayed using HSA synergy model.